Hepatitis
Wild Mushrooms: Good Enough To Die For?
Published in Medical Letter on the CDC and FDA, June 23rd, 1997
Amanita phalloides may account for approximately 90 percent of deaths from mushroom ingestion worldwide, said the U.S. Centers for Disease Control and Prevention (CDC) (MMWR, vol. 46/no. 22, June 6, 1997). The phalloidin toxin produced by the fungus halts protein synthesis in the liver, which results in severe acute hepatitis. Mushrooms in this fungal genus commonly are called "destroying angels."
A. phalloides, like most mushrooms, is not unique in appearance and can be mistaken for nonpoisonous mushrooms. A. phalloides has no...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Aedes aegypti Mosquito
Dengue And Yellow Fever Vector Has Re-Emerged In Arizona - Coinfection (HCV/HGV)
Evidence Suggests Hepatitis G Infection Does Not Worsen Hepatitis C Disease - Cyclosporiasis
April-May 1997 Outbreaks Due to Tainted, Imported Raspberries - Cyclosporiasis
U.S. Raspberries Remain Safe To Eat - Driscoll Berries Not Involved in Outbreak - Diptheria
Vaccination Essential to Prevent Re-Emergence of Diptheria - Epidemiology (Viruses)
Drug Resistance, Over-Population, Transmission Worry CDC - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
